OALBF0104	Education as an enabling factor to HIV prevention and adherence to treatment	Oral abstract session with live Q&A	Access to education
OALBF0105	Strengthening TB/HIV human rights programming to overcome barriers to accessing TB services	Oral abstract session with live Q&A	Human rights programmes
OALBX0102	Transcriptional programs of HIV silencing and cell survival in HIV-infected memory CD4 T cells under antiretroviral therapy	Oral abstract session with live Q&A	Host cellular factors and viral mechanisms of HIV/SIV persistence and latency
OALBX0103	Doxycycline post-exposure prophylaxis for STI prevention among MSM and transgender women on HIV PrEP or living with HIV: high efficacy to reduce incident STI's in a randomized trial	Oral abstract session with live Q&A	STIs (including HPV)
OALBX0105	Week 48 results of a Phase 3 randomized controlled trial of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) vs dolutegravir + emtricitabine/tenofovir Disoproxil Fumarate (DTG+F/TDF) as initial treatment in HIV/HBV-coinfected adults (ALLIANCE)	Oral abstract session with live Q&A	Viral hepatitis C and other viral hepatitis (e.g., A, B, D, E)
OALBX0106	Trends in PrEP inequity by race and census region, United States, 2012-2021	Oral abstract session with live Q&A	Scale up of PrEP
OALBX0107	Long acting cabotegravir: updated efficacy and safety results from HPTN 084	Oral abstract session with live Q&A	Other new HIV prevention tools
EPA001	Single-cell sequencing of simian immunodeficiency virus DNA provides improved resolution of reservoir viral evolution and evidence of selection for long-range co-evolution	E-poster	Viral origins, evolution and diversity
EPA002	Non-canonical role of Hsp90 isoforms in HIV-1 infection	E-poster	HIV biology (entry, replicative cycle, transcriptional expression and regulation)
EPA003	Characterization of novel candidate factors impacting HIV life cycle	E-poster	HIV biology (entry, replicative cycle, transcriptional expression and regulation)